Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;30(2):97-105.
doi: 10.1017/neu.2017.29. Epub 2017 Nov 29.

Neurological soft signs significantly differentiate schizophrenia patients from healthy controls

Affiliations

Neurological soft signs significantly differentiate schizophrenia patients from healthy controls

Konstantinos N Fountoulakis et al. Acta Neuropsychiatr. 2018 Apr.

Erratum in

Abstract

Objective: Neurological soft signs (NSS) are a group of minor non-localisable neurological abnormalities found more often in patients with schizophrenia. The aim of the current study was to test for the effect of gender, age, parental age, age at onset and clinical symptomatology on NSS.Material and methodsThe study sample included 133 patients suffering from schizophrenia according to DSM-IV-TR (77 males and 56 females; aged 33.55±11.22 years old) and 122 normal controls (66 males and 56 females; aged 32.89±9.91 years old). The assessment included the Neurological Evaluation Scale (NES), and a number of scales assessing the clinical symptoms and adverse effects especially extrapyramidal. The statistical analysis included exploratory t-test, simple linear regression analysis, analysis of covariance and the calculation of correlation coefficients.

Results: The results of the current study confirm that NSS are more frequent in patients with schizophrenia in comparison with normal controls (Wilks=0.622, p<0.0001), but do not support an effect of gender, age, age at onset, paternal or maternal age, education, medication status or clinical subtype of schizophrenia on NES scores.DiscussionOverall these results suggest that NSS constitute an independent (from the rest of symptoms), core (present in the vast majority of patients) and trait (unrelated to age and probably to the stage of schizophrenia) symptom of schizophrenia which could be of value in the clinical assessment and research of schizophrenia. Overall these results are not in full accord with the literature, but they could serve to fill in gaps and inconsistencies observed so far.

Keywords: motor coordination; neurological abnormalities; schizophrenia; soft neurological signs.

PubMed Disclaimer

Similar articles

Cited by

  • The neural substrates of neurological soft signs in schizophrenia: a systematic review.
    Samson GD, Lahti AC, Kraguljac NV. Samson GD, et al. Schizophrenia (Heidelb). 2022 Apr 26;8(1):42. doi: 10.1038/s41537-022-00245-9. Schizophrenia (Heidelb). 2022. PMID: 35853869 Free PMC article. Review.
  • One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.
    Fountoulakis KN, Panagiotidis P, Theofilidis AT, Nimatoudis I. Fountoulakis KN, et al. Clin Psychopharmacol Neurosci. 2020 Aug 31;18(3):434-444. doi: 10.9758/cpn.2020.18.3.434. Clin Psychopharmacol Neurosci. 2020. PMID: 32702222 Free PMC article.
  • Longitudinal trajectory of early functional recovery in patients with first episode psychosis.
    Hall MH, Holton KM, Öngür D, Montrose D, Keshavan MS. Hall MH, et al. Schizophr Res. 2019 Jul;209:234-244. doi: 10.1016/j.schres.2019.02.003. Epub 2019 Feb 28. Schizophr Res. 2019. PMID: 30826261 Free PMC article.
  • The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia.
    Petrescu C, Papacocea IR, Vilciu C, Mihalache OA, Vlad DM, Marian G, Focseneanu BE, Sima CT, Ciobanu CA, Riga S, Ciobanu AM. Petrescu C, et al. Biomedicines. 2022 Nov 15;10(11):2939. doi: 10.3390/biomedicines10112939. Biomedicines. 2022. PMID: 36428507 Free PMC article.
  • Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.
    Fountoulakis KN, Dragioti E, Theofilidis AT, Wikilund T, Atmatzidis X, Nimatoudis I, Thys E, Wampers M, Hranov L, Hristova T, Aptalidis D, Milev R, Iftene F, Spaniel F, Knytl P, Furstova P, From T, Karlsson H, Walta M, Salokangas RKR, Azorin JM, Bouniard J, Montant J, Juckel G, Haussleiter IS, Douzenis A, Michopoulos I, Ferentinos P, Smyrnis N, Mantonakis L, Nemes Z, Gonda X, Vajda D, Juhasz A, Shrivastava A, Waddington J, Pompili M, Comparelli A, Corigliano V, Rancans E, Navickas A, Hilbig J, Bukelskis L, Injac Stevovic L, Vodopic S, Esan O, Oladele O, Osunbote C, Rybakowski JΚ, Wojciak P, Domowicz K, Figueira ML, Linhares L, Crawford J, Panfil AL, Smirnova D, Izmailova O, Lecic-Tosevski D, Temmingh H, Howells F, Bobes J, Garcia-Portilla MP, García-Alvarez L, Erzin G, Karadağ H, De Sousa A, Bendre A, Hoschl C, Bredicean C, Papava I, Vukovic O, Pejuskovic B, Russell V, Athanasiadis L, Konsta A, Stein D, Berk M, Dean O, Tandon R, Kasper S, De Hert M. Fountoulakis KN, et al. Int J Neuropsychopharmacol. 2019 Nov 1;22(11):681-697. doi: 10.1093/ijnp/pyz053. Int J Neuropsychopharmacol. 2019. PMID: 31563956 Free PMC article.

LinkOut - more resources